Log In
C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.
Copyright © 2006 American Chemical Society
October 9, 2006 Cover
Volume 84, Issue 41
Volume 84, Issue 41
RICHARD E.SMALLEY
Richard Smalley left his mark on science by laying the foundation for nanotechnology as we know it, then he tried to save the world
Credit: Mark Thiessen/NationalGeographic Image Collection
» Full Article
October 9, 2006 Issue
Volume 84, Issue 41
October 9, 2006 Issue, Vol. 84 | Iss. 41
Richard Smalley left his mark on science by laying the foundation for nanotechnology as we know it, then he tried to save the world
(pp. 13-19)
Features
Science & Technology
Structural biologist revealed how genetic code is transcribed into RNA (p.7)
Business
Freeing propylene oxide from its coproducts has been elusive, but new plants may finally make it work (pp. 22-23)
Cover Story: The World According To Rick
News of the Week
Another Kornberg Nabs A Nobel
Structural biologist revealed how genetic code is transcribed into RNA
(p.7)Gilead Buys Myogen
Hot drug prospect justifies $2.5 billion sale price, Gilead says
(p.8)Award Honors Cosmology Studies
Pair shares prize for measurements of energy distribution in infant universe
(p.9)Supreme Court
Court to hear cases involving Clean Air Act, huge punitive damages
(p.9)Brighter Prospects
After several dismal years, fine chemicals companies are seeing industry stabilization
(p.10)National Security
Congress Focuses On Security Before Adjourning
(p.10)Boron Attacks
Electropositive element pressed into action as nucleophilic boryllithium
(p.11)Cigarettes' Smoking Gun?
Acrolein causes DNA mutations similar to those found in lung cancer
(p.11)Brain Chemistry
Molecular clue links ALS to other dire ailments
(p.12)First Synthesis Of Platensimycin
Work could ease way to improved analogs of unique antibiotic natural product
(p.12)Departments
Business
Freeing propylene oxide from its coproducts has been elusive, but new plants may finally make it work
(pp. 22-23)
AstraZeneca's Boston site offers a window into how a big drug firm plans to regain its competitive edge
(pp. 24-25)Concentrates
(pp. 20-21)
(pp. 20-21)- REACH legislation in home stretch
- Honeywell ups caprolactam
- Baytown blast restricts TDI
- Chevron, DOE study biofuels
- PTC awarded biowarfare drug contract
- Air Products takes a charge ...
- ... and plans Korean NF3
- Ciba divests masterbatches
- Grace sets up biofuels group
- DSM acquires lipid company
- Shipments up in August
- Mitsui buys agchem unit
- Amgen to buy biotech Avidia
- Plexxikon will partner with Roche, Servier
- Altana closing U.S. R&D site
- UCB, Biogen form MS pact
- GSK and Roche boost flu drugs
- BUSINESS ROUNDUP
- All Concentrates
ACS News
San Francisco council discussion features advice on how to engage younger chemists as leaders of ACS
(pp. 39-40)Awards(pp. 41-42)
(pp. 41-42)
Government & Policy
Dow is midway through a 20-year efficiency program that aims to cut energy use in half by 2015
(pp. 28-29)
Congress, National Academies report push for more environment and safety impact studies
(p.30)Books
Science & Technology
Richard Smalley left his mark on science by laying the foundation for nanotechnology as we know it, then he tried to save the world
(pp. 13-19)
Researchers believe enzyme could be a nearly universal target for anticancer drugs
(pp. 32-33)
Rigging the world with chemical sensors is a technical challenge with big potential payoffs
(p.34)
Technology and Business News for the Laboratory World
(p.35)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings